These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9239808)

  • 1. Early skin response to fractionated doses of pions for determining therapeutic gain factors.
    Ohizumi Y; Lam GK; Pickles T; Chaplin DJ
    Tokai J Exp Clin Med; 1996 Jun; 21(2):69-75. PubMed ID: 9239808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
    Ohizumi Y; Lam GK; Pickles T; Fryer C; Chaplin DJ
    Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
    el-Said A; Menke D; Dorie MJ; Brown JM
    Radiat Oncol Investig; 1999; 7(3):163-9. PubMed ID: 10406058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.
    Song CW; Lee I; Hasegawa T; Rhee JG; Levitt SH
    Cancer Res; 1987 Jan; 47(2):442-6. PubMed ID: 3098409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR; Overgaard J
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
    Lee I; Levitt SH; Song CW
    Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin.
    Sun JR; Brown JM
    Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ; Horsman MR; Siemann DW
    Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of nicotinamide plus carbogen or pions for microscopic SCCVII tumors.
    Nishioka A; Ohizumi Y; Lam GK; Pickles TA; Chaplin DJ; Ogawa Y; Inomata T; Yoshida S
    Oncol Rep; 1999; 6(3):583-6. PubMed ID: 10203595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide as a repair inhibitor in vivo: studies using single and fractionated X-ray doses in mouse skin and kidneys.
    Rojas A; Denekamp J; Johns H; Kjellen E; Tsang R; Nilsson P; Stratford MR; Dennis MF; Joiner MC
    Radiat Res; 1996 Apr; 145(4):419-31. PubMed ID: 8600502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
    Rojas A; Vojnovic B; Johns H; Joiner MC; Martindale C; Fowler JF; Denekamp J
    Radiother Oncol; 1996 Apr; 39(1):53-64. PubMed ID: 8735494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The response of mouse tumours to fractionated doses of pions: determination of therapeutic gain factor.
    Ogawa Y; Goodman GB; Chaplin DJ; Grulkey W; Lam GK
    Oncology; 1991; 48(1):81-7. PubMed ID: 1987502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide.
    Brizel DM; Hage WD; Dodge RK; Munley MT; Piantadosi CA; Dewhirst MW
    Radiat Res; 1997 Jun; 147(6):715-20. PubMed ID: 9189170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells.
    Horsman MR; Chaplin DJ; Overgaard J
    Cancer Res; 1990 Dec; 50(23):7430-6. PubMed ID: 2147577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ; Menke D; Brown JM
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors.
    Brown JM; Lemmon MJ
    Cancer Res; 1990 Dec; 50(24):7745-9. PubMed ID: 2253217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of tumor hypoxia and inhibition of DNA repair by nicotinamide after irradiation of SCCVII murine tumors and normal tissues.
    Zheng H; Olive PL
    Cancer Res; 1996 Jun; 56(12):2801-8. PubMed ID: 8665517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys.
    Rojas A; Joiner MC; Hodgkiss RJ; Carl U; Kjellen E; Wilson GD
    Int J Radiat Oncol Biol Phys; 1992; 23(2):361-6. PubMed ID: 1587757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological effectiveness of fractionated dose of pions in microscopic SCCVII tumors: comparison between tumor control dose and tumor growth time assays.
    Ohizumi Y; Lam GK; Pickles T; Chaplin DJ
    Jpn J Cancer Res; 1995 Jun; 86(6):600-6. PubMed ID: 7622425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing.
    Siemann DW; Horsman MR; Chaplin DJ
    Radiother Oncol; 1994 May; 31(2):117-22. PubMed ID: 8066190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.